Skip to content

Effect of varicocele correction surgery on the quality of sperm

Varicocelectomy effect on the spermatic DNA fragmentation: clinical trial with random assignment of participants

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5zy6vw
Enrollment
Unknown
Registered
2015-06-24
Start date
2013-02-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicocele

Interventions

40 men with varicocele will be evaluated as to the effect of the surgery of varicocele correction in sperm DNA fragmentation, sperm quality and hormonal parameters. There will be randomly allocated in
Procedure/surgery

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico
Lead Sponsor
Faculdade de Medicina de Ribeirão Preto
Collaborator

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Men with varicocele in grades II and III; aged between 18 and 45; not having undergone previous varicocelectomy.

Exclusion criteria

Exclusion criteria: Smoking; excessive use of alcohol; drug abuse; genetic damage; prior varicocele correction surgery; testicular trauma; urogenital infections suspicion; cancer; endocrinopathies; treatments that may influence the testicular functions.

Design outcomes

Primary

MeasureTime frame
Difference in sperm DNA fragmentation rate, semen quality and hormonal parameters in men with varicocele who underwent or not to varicocelectomy, verified by comparative analysis before and after nine months of intervention. For the evaluation of outcomes will be used Halosperm G2® kit for the analysis of sperm DNA fragmentation rate, spermogram following the normal range indicated by the World Health Organization (2010) to assess the seminal quality, and serum levels of hormones FHS, LH, prolactin, SHBG and FAI for hormonal evaluation. A determination of whether there are differences between the parameters evaluated before and after nine months will be made, and from statistical analysis between groups, the changes are considered significant to achieve p <0.05.

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactRosana;Rosana dos Reis;Reis

Faculdade de Medicina de Ribeirão Preto;Faculdade de Medicina de Ribeirão Preto

romareis@fmrp.usp.br;romareis@fmrp.usp.br+55(16)3602 2926;+55 (16) 3315 2815

Outcome results

None listed

Source: REBEC (via WHO ICTRP)